Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
staff position within a Research Infrastructure? No Offer Description Come to CEITEC MU in Brno and join us! We are passionate chemists at CEITEC Masaryk University looking for Two PhD Candidates/Students
-
staff position within a Research Infrastructure? No Offer Description Come to CEITEC MU in Brno and join us! We are passionate chemists at CEITEC Masaryk University looking for PhD Candidate/Student in
-
antibodies and anti-CD20 CAR T-cells form the backbone of treatment for mature B cell malignancies. The project focuses on elucidating changes in gene expression within the tumor microenvironment of chronic
-
Sep 13. PMID: 25080849 Review. Research area: Cancer biology Keywords: lymphoma, CLL, migration, microenvironment, co-culture Funding for the PhD candidate: In the academic year 2026/27 the net
-
the PhD student using technics such as genome editing (CRISPR), RNA sequencing, use of primary samples, functional studies with various in vitro and in vivo mouse models. The research is also relevant
-
scholarship + CEITEC PhD School scholarship. Requirements on candidates: Motivated smart people that have the “drive” to work independently, but also willing to learn from other people in the lab and
-
), which establishes and maintains transcriptionally silent chromatin states. This PhD project aims to investigate how structural and biochemical features of these Polycomb proteins determine their
-
novel regulators of the B cell survival, proliferation and crosstalk with other immune cells. The PhD student will further investigate this using techniques such as genome editing (CRISPR), RNA sequencing
-
https://pubmed.ncbi.nlm.nih.gov/36596869/ Research area: Cancer biology Keywords: lymphoma, CLL, lncRNA, microenvironment Funding of the PhD candidate: Part-time salary (min. 0,5 FTE) on EHA grant/AZV
-
Supervisor: prof. RNDr. Robert Vácha, PhD. Topic title: Designing Coiled-Coil Peptides for Controlled Membrane Fusion and Intracellular Delivery Annotation: Most approved drugs act on cell-surface targets